In this study, we utilized patient-derived induced pluripotent stem cells (iPSCs) to model TCIRG1-associated neutropenia and elucidate the mechanistic consequences of TCIRG1 mutations on myeloid differentiation. Here, TCIRG1 is linked to neutropenia.